Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.info:eu-repo/semantics/publishedVersio
Objectives: The aim of this study was to determine the prognostic value of fractional flow reserve (...
Reperfusion therapy of the infarct-related artery (IRA) with primary percutaneous coronary intervent...
There remains a clinical question of which patients benefit from revascularization of non-culprit co...
Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarcti...
Background: In the setting of ST-elevation myocardial infarction (STEMI) and multi-vessel disease (M...
Approximately 50% of patients presenting with an acute ST-segment elevation myocardial infarction (S...
In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervent...
The aim of this study is to analyze the new existing evidence and provide an updated insight into th...
Understanding the similarities and differences between myocardial infarction with or without ST-segm...
BACKGROUND: In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous corona...
Primary PCI of infarct-related arteries is the preferred reperfusion strategy in patients presenting...
Objectives We sought to evaluate the physiology of non-culprit lesions by using vessel fractional fl...
Patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease (MVD) have...
International audienceAims: Periprocedural myocardial infarctions have been reported in the setting ...
ObjectivesThe present report describes patients with acute ST-elevation myocardial infarction who ha...
Objectives: The aim of this study was to determine the prognostic value of fractional flow reserve (...
Reperfusion therapy of the infarct-related artery (IRA) with primary percutaneous coronary intervent...
There remains a clinical question of which patients benefit from revascularization of non-culprit co...
Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarcti...
Background: In the setting of ST-elevation myocardial infarction (STEMI) and multi-vessel disease (M...
Approximately 50% of patients presenting with an acute ST-segment elevation myocardial infarction (S...
In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervent...
The aim of this study is to analyze the new existing evidence and provide an updated insight into th...
Understanding the similarities and differences between myocardial infarction with or without ST-segm...
BACKGROUND: In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous corona...
Primary PCI of infarct-related arteries is the preferred reperfusion strategy in patients presenting...
Objectives We sought to evaluate the physiology of non-culprit lesions by using vessel fractional fl...
Patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease (MVD) have...
International audienceAims: Periprocedural myocardial infarctions have been reported in the setting ...
ObjectivesThe present report describes patients with acute ST-elevation myocardial infarction who ha...
Objectives: The aim of this study was to determine the prognostic value of fractional flow reserve (...
Reperfusion therapy of the infarct-related artery (IRA) with primary percutaneous coronary intervent...
There remains a clinical question of which patients benefit from revascularization of non-culprit co...